We are excited to be a part of a Lancet Oncology Commission focusing on cancer genomics and precision oncology. This new commission will be coordinated by the International Cancer Genome Consortium Accelerating Research in Genomic Oncology (ICGC-ARGO) initiative, and bring together international experts with relevant expertise across a range of fields, to offer practical solutions for key challenges in ensuring sustainable and equitable access to omics testing and a blueprint for advancing cancer diagnosis and treatment.
Our center focuses on data-driven cancer research by applying high-throughput genomic, transcriptomic and proteomic approaches, to characterize molecular landscapes of gastrointestinal cancer for identifying clinical biomarkers and novel therapeutic targets. At the same time, we are also interested to develop analysis tools and databases, to facilitate and accelerate translational research in cancer. Recently, in close collaboration with a number of national/international clinical leads and technology leaders, we initiated an ICGC-ARGO program in Gastric Cancer.
